Daily Recap
Quiet summer session for U.S Cannabis with ~$15M notional plant-touching volume (allowing for double accounting) ahead of quarter-end on Friday/ next week’s holiday.
The landscape for operators remains challenged and uneven on this, day 866 since the U.S cannabis market topped; the status quo has been unkind to this space.
TerrAscend listing on the TSX is the nearest-term catalyst we know of that has the potential to shake things up; an update of other potential catalysts can be found here.
We’ll be trialing this format/ content/ style to see if Substack+ gets sticky ahead of what we expect will be an eventful 2H23 for this industry and it’s people.
zei gezunt
Today’s Top Stories
UN Experts Call for End to Global ‘War on Drugs’
Push to get Ohio Adult-Use on the Ballot
AYR Reaches Contingent Agreements to Defer ~$69M of Promissory Note Payments
Glass House Brands Sues Catalyst Cannabis for Defamation Over Diversion Claims
Cannabis Coalition Makes Case for De-scheduling in New White Paper
Study: Chronic Cannabis Use Shows Promise to Prevent Brain Damage in Athletes
Maryland Readies Recreational Cannabis Market Kickoff on July 1st
TerrAscend Upsizes Previously Announced Offering to $20M; Closes initial $16M.
^ OSU Podcast: Changes in Federal Approaches to Cannabis: Process and Impact. I am trying to educate myself on the various processes and protocols involved in the ongoing expedited scheduling review and found it to be informative.
Keep reading with a 7-day free trial
Subscribe to Cannabis Confidential to keep reading this post and get 7 days of free access to the full post archives.